The enrichment of the OCT4+ cell fraction suggests that tumor cells persisting after drug treatment acquire cancer stem-like properties, including enhanced resistance to therapy, thereby increasing the risk of disease recurrence [6–8]. The gene discussed is POU5F1; the disease is neoplasm.